Years of translational research have successfully improved treatment outcomes for common dermatological conditions such as ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...

Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic ...